Related references
Note: Only part of the references are listed.A Radical View on the Contractile Machinery in Human Heart Failure
Gerd Heusch et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice
Janine Poess et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function
Vedat Tiyerili et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation
Efstathios K. Iliodromitis et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
NADPH oxidases in cardiovascular disease
Ralf P. Brandes et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Targeting reactive oxygen species in hypertension
Christian Delles et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Nox4 and Nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation
Narayana Anilkumar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Reduced nicotinamide adenine dinucleotide phosphate oxidase-derived superoxide and vascular endothelial dysfunction in human heart failure
Rafal Dworakowski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II - Studies in endothelial-targeted Nox2 transgenic mice
Jennifer K. Bendall et al.
CIRCULATION RESEARCH (2007)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Hypertension caused by transgenic overexpression of Rac 1
Hamdy H. Hassanain et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase
Sofian Johar et al.
FASEB JOURNAL (2006)
Reactive oxygen species in the neuropathogenesis of hypertension
Jeffrey R. Peterson et al.
CURRENT HYPERTENSION REPORTS (2006)
Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload
DJ Grieve et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Decreased blood pressure in NOX1-deficient mice
G Gavazzi et al.
FEBS LETTERS (2006)
Nox1 is involved in angiotensin II-mediated hypertension - A study in Nox1-deficient mice
K Matsuno et al.
CIRCULATION (2005)
Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice
A Dikalova et al.
CIRCULATION (2005)
Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase
RM Touyz et al.
HYPERTENSION (2005)
gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension
O Jung et al.
CIRCULATION (2004)
Nox enzymes and the biology of reactive oxygen
JD Lambeth
NATURE REVIEWS IMMUNOLOGY (2004)
Dose-dependent regulation of NAD(P)H oxidase expression b angiotensin II in human endothelial cells - Protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease
U Rueckschloss et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Vascular superoxide production by NAD(P)H oxidase - Association with endothelial dysfunction and clinical risk factors
TJ Guzik et al.
CIRCULATION RESEARCH (2000)
Share Paper
